BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3780475)

  • 1. Effect of non-steroidal anti-inflammatory drugs on the human small intestine.
    Bjarnason I; Zanelli G; Prouse P; Williams P; Gumpel MJ; Levi AJ
    Drugs; 1986; 32 Suppl 1():35-41. PubMed ID: 3780475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.
    Bjarnason I; Williams P; So A; Zanelli GD; Levi AJ; Gumpel JM; Peters TJ; Ansell B
    Lancet; 1984 Nov; 2(8413):1171-4. PubMed ID: 6150232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.
    Bjarnason I; Fehilly B; Smethurst P; Menzies IS; Levi AJ
    Gut; 1991 Mar; 32(3):275-7. PubMed ID: 1901563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine.
    Bjarnason I; Williams P; Smethurst P; Peters TJ; Levi AJ
    Gut; 1986 Nov; 27(11):1292-7. PubMed ID: 3466837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental evidence of the benefit of misoprostol beyond the stomach in humans.
    Bjarnason I
    J Rheumatol Suppl; 1990 Feb; 20():38-41. PubMed ID: 2109075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal permeability and inflammation in patients on NSAIDs.
    Sigthorsson G; Tibble J; Hayllar J; Menzies I; Macpherson A; Moots R; Scott D; Gumpel MJ; Bjarnason I
    Gut; 1998 Oct; 43(4):506-11. PubMed ID: 9824578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study.
    Bours MJ; Bos HJ; Meddings JB; Brummer RJ; van den Brandt PA; Dagnelie PC
    BMC Gastroenterol; 2007 Jun; 7():23. PubMed ID: 17578566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis and consequence of non steroidal anti-inflammatory drug induced small intestinal inflammation in man.
    Bjarnason I; Zanelli G; Smith T; Smethurst P; Price AB; Gumpel MJ; Levi AJ
    Scand J Rheumatol Suppl; 1987; 64():55-62. PubMed ID: 3324305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of bile in pathogenesis of indomethacin-induced enteropathy.
    Jacob M; Foster R; Sigthorsson G; Simpson R; Bjarnason I
    Arch Toxicol; 2007 Apr; 81(4):291-8. PubMed ID: 17151867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs.
    Bjarnason I; Zanelli G; Prouse P; Smethurst P; Smith T; Levi S; Gumpel MJ; Levi AJ
    Lancet; 1987 Sep; 2(8561):711-4. PubMed ID: 2888943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local effect of adenosine 5'-triphosphate on indomethacin-induced permeability changes in the human small intestine.
    Bours MJ; Troost FJ; Brummer RJ; Bast A; Dagnelie PC
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):245-50. PubMed ID: 17301652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of non-steroidal anti-inflammatory drug induced enteropathy.
    Bjarnason I; Hopkinson N; Zanelli G; Prouse P; Smethurst P; Gumpel JM; Levi AJ
    Gut; 1990 Jul; 31(7):777-80. PubMed ID: 1973396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of anti-rheumatic drugs on gut permeability and on the gut associated lymphoid tissue.
    Bjarnason I; Peters TJ
    Baillieres Clin Rheumatol; 1996 Feb; 10(1):165-76. PubMed ID: 8674146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small bowel permeability--a variable effect of NSAIDS.
    Choi VM; Coates JE; Chooi J; Thomson AB; Russell AS
    Clin Invest Med; 1995 Oct; 18(5):357-61. PubMed ID: 8529318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiinflammatory drug-induced small intestinal permeability: the rat is a suitable model.
    Davies NM; Wright MR; Jamali F
    Pharm Res; 1994 Nov; 11(11):1652-6. PubMed ID: 7870685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining small bowel integrity following drug treatment.
    Smale S; Bjarnason I
    Br J Clin Pharmacol; 2003 Sep; 56(3):284-91. PubMed ID: 12919176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do non-steroidal anti-inflammatory drugs increase colonic permeability?
    Jenkins AP; Trew DR; Crump BJ; Nukajam WS; Foley JA; Menzies IS; Creamer B
    Gut; 1991 Jan; 32(1):66-9. PubMed ID: 1899408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo influence of nicotine on human basal and NSAID-induced gut barrier function.
    Suenaert P; Bulteel V; Den Hond E; Geypens B; Monsuur F; Luypaerts A; Ghoos Y; Rutgeerts P
    Scand J Gastroenterol; 2003 Apr; 38(4):399-408. PubMed ID: 12739712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect?
    Morris AJ; Howden CW; Robertson C; Duncan A; Torley H; Sturrock RD; Russell RI
    Gut; 1991 Dec; 32(12):1470-2. PubMed ID: 1773950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.
    Bjarnason I; Hayllar J; MacPherson AJ; Russell AS
    Gastroenterology; 1993 Jun; 104(6):1832-47. PubMed ID: 8500743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.